Variant report
Variant | esv2762264 |
---|---|
Chromosome Location | chr2:77202107-77206452 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187548023 | chr2:77202124-77202125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs375283614 | chr2:77202156-77202157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs17333926 | chr2:77202157-77202158 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs371291433 | chr2:77202159-77202160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536101979 | chr2:77202195-77202196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114249101 | chr2:77202196-77202197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554239251 | chr2:77202206-77202207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145446637 | chr2:77202228-77202229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575873016 | chr2:77202246-77202247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372177453 | chr2:77202265-77202266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566936814 | chr2:77202318-77202319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527915854 | chr2:77202327-77202328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs111732501 | chr2:77202335-77202336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536833116 | chr2:77202369-77202370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs116325752 | chr2:77202388-77202389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs550377268 | chr2:77202630-77202631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571331496 | chr2:77202656-77202657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565259328 | chr2:77202726-77202727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192588794 | chr2:77202728-77202729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1446710 | chr2:77202747-77202748 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs151004647 | chr2:77202758-77202759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183692197 | chr2:77202759-77202760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs77633556 | chr2:77202835-77202836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569592235 | chr2:77202866-77202867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186835479 | chr2:77202911-77202912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1446711 | chr2:77202938-77202939 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs376114929 | chr2:77202945-77202946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs71420984 | chr2:77202961-77202962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200203589 | chr2:77202971-77202972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201879377 | chr2:77202973-77202974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs72823135 | chr2:77203017-77203018 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs534664563 | chr2:77203037-77203038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552786716 | chr2:77203067-77203068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544013016 | chr2:77203118-77203119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541833710 | chr2:77203140-77203141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562435295 | chr2:77203145-77203146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144767571 | chr2:77203155-77203156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191713123 | chr2:77203164-77203165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1446712 | chr2:77203168-77203169 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs74718857 | chr2:77203193-77203194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111588853 | chr2:77203237-77203238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142831979 | chr2:77203259-77203260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184295651 | chr2:77203288-77203289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548148833 | chr2:77203318-77203319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569629346 | chr2:77203331-77203332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536904971 | chr2:77203332-77203333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs6722490 | chr2:77203359-77203360 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs74650624 | chr2:77203402-77203403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7599667 | chr2:77203426-77203427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs72823136 | chr2:77203493-77203494 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Epilepsy | 22083797 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:77202000-77202400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr2:77202600-77204200 | Enhancers | HUVEC | blood vessel |
3 | chr2:77203000-77206600 | Enhancers | Fetal Lung | lung |
4 | chr2:77203800-77206800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
5 | chr2:77204200-77204600 | Weak transcription | HUVEC | blood vessel |
6 | chr2:77204600-77206200 | Enhancers | HUVEC | blood vessel |
7 | chr2:77204800-77205400 | Enhancers | Rectal Smooth Muscle | rectum |
8 | chr2:77205000-77206800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
9 | chr2:77206200-77211200 | Weak transcription | HUVEC | blood vessel |